$388 Million is the total value of Canaan Partners XI LLC's 6 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DAWN | New | DAY ONE BIOPHARHACEUTICALS I | $162,832,000 | – | 9,663,645 | +100.0% | 41.94% | – |
| AEVA | New | AEVA TECHNOLOGIES INC | $139,748,000 | – | 18,485,197 | +100.0% | 36.00% | – |
| New | TYRA BIOSCIENCES INC | $62,049,000 | – | 4,409,991 | +100.0% | 15.98% | – | |
| New | RALLYBIO CORP | $22,989,000 | – | 2,409,712 | +100.0% | 5.92% | – | |
| New | BIRD GLOBAL INC | $427,000 | – | 69,270 | +100.0% | 0.11% | – | |
| VECT | New | VECTIVBIO HLDG AG | $182,000 | – | 37,051 | +100.0% | 0.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-03
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DAY ONE BIOPHARMACEUTICALS I | 8 | Q3 2023 | 61.6% |
| TYRA BIOSCIENCES INC | 8 | Q3 2023 | 53.3% |
| AEVA TECHNOLOGIES INC | 8 | Q3 2023 | 36.0% |
| RALLYBIO CORP | 8 | Q3 2023 | 14.1% |
| VECTIVBIO HLDG AG | 7 | Q2 2023 | 0.3% |
| BIRD GLOBAL INC | 5 | Q4 2022 | 0.1% |
| MONEYLION INC | 1 | Q3 2023 | 1.4% |
| MONEYLION INC | 1 | Q2 2023 | 0.6% |
View Canaan Partners XI LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-05 |
| 13F-HR | 2024-02-01 |
| 13F-HR | 2023-10-11 |
| 13F-HR | 2023-07-13 |
| 13F-HR | 2023-04-06 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-10-31 |
| 4 | 2022-09-22 |
| 4 | 2022-09-20 |
| 4 | 2022-09-15 |
View Canaan Partners XI LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.